Patient Reported Outcome Measures in Adults with Fontan Circulatory Failure.
Guillermo AgorrodyIsaac BegunSubodh VermaC David MazerMaria Luz GaragiolaBeatriz Fernandez-CamposRonald AcuñaKatherine KearneyAlvan BuckleyNitish K DhingraEhsan GhamarianS Lucy RocheRafael Alonso-GonzalezRachel M WaldPublished in: Journal of clinical medicine (2024)
Background: Patient reported outcomes (PROs) are important measures in acquired heart disease but have not been well defined in Adult Congenital Heart Disease (ACHD). Our aim was to explore the discriminatory capacity of PRO survey tools in Fontan circulatory failure (FCF). Methods: Consecutive adults were enrolled from our ambulatory clinics. Inclusion criteria were age ≥18 years, a Fontan circulation or a hemodynamically insignificant shunt lesion, and sufficient cognitive/language abilities to complete PROs. A comprehensive package of PRO measures, designed to assess perceived health-related quality of life (HRQOL) was administered (including the Kansas City Cardiomyopathy Questionnaire [KCCQ-12], EuroQol-5-dimension [EQ5D], Short Form Health Status Survey [SF-12], self-reported New York Heart Association [NYHA] Functional Class, and Specific Activity Scale [SAS]). Results: We compared 54 Fontan patients (35 ± 10 years) to 25 simple shunt lesion patients (34 ± 11 years). The KCCQ-12 score was lower in Fontan versus shunt lesion patients (87 [IQR 79, 95] versus 100 [IQR 97, 100], p -value < 0.001). The FCF subgroup was associated with lower KCCQ-12 scores as compared with the non-FCF subgroup (82 [IQR 56, 89] versus 93 [IQR 81, 98], p -value = 0.002). Although the KCCQ-12 had the best discriminatory capacity for determination of FCF of all PRO tools studied (c-statistic 0.75 [CI 0.62, 0.88]), superior FCF discrimination was achieved when the KCCQ-12 was combined with all PRO tools (c-statistic 0.82 [CI 0.71, 0.93]). Conclusions: The KCCQ-12 questionnaire demonstrated good discriminatory capacity for the identification of FCF, which was further improved through the addition of complementary PRO tools. Further research will establish the value of PRO tools to guide management strategies in ACHD.
Keyphrases
- patient reported outcomes
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- anti inflammatory
- prognostic factors
- congenital heart disease
- heart failure
- primary care
- peritoneal dialysis
- cross sectional
- blood pressure
- patient reported
- physical activity
- randomized controlled trial
- pulmonary artery
- mass spectrometry
- study protocol
- pulmonary arterial hypertension
- simultaneous determination
- tandem mass spectrometry